Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

psychiatric diseases

- PMLiVE

Novartis launches another localised NHS eye service in UK

Will provide specialised care to people of Coventry

- PMLiVE

Boehringer drug approved in EU for rare lung disease

Nintedanib is already available as cancer treatment

- PMLiVE

Boehringer partners with US universities

Will work with Yale and Vanderbilt on cancer projects

- PMLiVE

AZ signs yet another cancer immunotherapy deal

Will work with Omnis to develop viruses that target tumour cells

Pharma deals during December 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for December 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

NICE recommends Pradaxa in blood clot indication

Boehringer drug backed to treat and prevent deep vein thrombosis and pulmonary embolism

- PMLiVE

ASH: Pradaxa antidote effective in key patient groups

Boehringer posts positive data on use of idarucizumab in elderly and people with kidney impairment

Pharma deals during November 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for November 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Campaigns recognised at German health comms awards

Schmittgall, Pink Carrots and S&H among the winners

Sanofi reception

Sanofi and Evotec discuss high-level outsourcing alliance

Partnership to focus on cancer drug discovery

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links